550 related articles for article (PubMed ID: 18219130)
1. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
Talay F; Kumbetli S; Altin S
Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
[TBL] [Abstract][Full Text] [Related]
2. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
[TBL] [Abstract][Full Text] [Related]
4. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
5. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
6. The treatment of multidrug-resistant tuberculosis in Turkey.
Tahaoğlu K; Törün T; Sevim T; Ataç G; Kir A; Karasulu L; Ozmen I; Kapakli N
N Engl J Med; 2001 Jul; 345(3):170-4. PubMed ID: 11463011
[TBL] [Abstract][Full Text] [Related]
7. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
8. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
[TBL] [Abstract][Full Text] [Related]
9. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.
Vree M; Huong NT; Duong BD; Sy DN; Van le N; Co NV; Cobelens FG; Borgdorff MW
BMC Public Health; 2007 Jul; 7():134. PubMed ID: 17605770
[TBL] [Abstract][Full Text] [Related]
10. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Khodashova ML; Iuditskiĭ MV; Semenova OV
Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
[TBL] [Abstract][Full Text] [Related]
11. Antituberculosis drug resistance and associated risk factors in the European section of Turkey.
Karabay O; Otkun M; Akata F; Karlikaya C; Tuğrul M; Dündar V
Indian J Chest Dis Allied Sci; 2004; 46(3):171-7. PubMed ID: 15553205
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
13. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand.
Anunnatsiri S; Chetchotisakd P; Wanke C
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):324-30. PubMed ID: 15916037
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.
Kim HJ; Hong YP; Kim SJ; Lew WJ; Lee EG
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771
[TBL] [Abstract][Full Text] [Related]
16. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
18. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
19. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome.
Karagöz T; Yazicioğlu Moçin O; Pazarli P; Senol T; Yetiş Duman D; Duman G; Saltürk C; Unal O; Halezeroğlu S
Tuberk Toraks; 2009; 57(4):383-92. PubMed ID: 20037853
[TBL] [Abstract][Full Text] [Related]
20. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
